SILVIS, Ill. -- John Senden was named this week’s AstraZeneca Charity Challenge winner for his first-place standing entering the final round of the John Deere Classic. Senden is holding the first 54-hole lead of his career, three strokes ahead of Heath Slocum and Patrick Sheehan. The AstraZeneca Charity Challenge, formerly known as the CRESTOR® Charity Challenge, is a season-long competition that recognizes and rewards the tournament leader entering the final round at 35 PGA TOUR events. Through the sponsorship, AstraZeneca will donate $3.5 million this year to designated health care charities and will have donated a three-year total of $9.7 million by the conclusion of the 2006 PGA TOUR season.

For Senden’s performance, AstraZeneca will donate $50,000 to the American Academy of Family Physicians Foundation (AAFP) and $50,000 to the American Osteopathic Foundation (AOF), on behalf of Senden and the John Deere Classic. AOF is headquartered in Chicago, Ill.

“We are extremely grateful to be the recipient of this generous donation from the AstraZeneca Charity Challenge,” said Dr. Jerry Rogers, president of the American Academy of Family Physicians Foundation. “AstraZeneca’s donation will help support our Health Communication project, which was established to promote better health communication between family physicians and their patients.”

“We are honored to be a 2006 recipient of the AstraZeneca Charity Challenge,” says Stephen Downey, executive director of the American Osteopathic Foundation. “Improving healthcare and the quality of our patients’ lives are just two of the goals we are proud to share with AstraZeneca. This donation will enable us to continue our mission in supporting osteopathic programs that enhance the profession and recognize excellence in the areas of osteopathic medical education and research.”

AstraZeneca produces a wide range of products that make significant contributions to treatment options and patient care including CRESTOR, NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year’s sponsorship, as part of its commitment to patient health and well being, AstraZeneca will also designate health care related charities across therapeutic areas as recipients at the 35 PGA TOUR events throughout the year.

“AstraZeneca’s partnership with the PGA TOUR is an integral part of our mission of giving back in local communities throughout America,” said Tony Zook, CEO, AstraZeneca U.S. “The AstraZeneca Charity Challenge offers a unique platform for providing important disease awareness, health information and education to make a difference in the lives of patients and consumers everyday.”

The AstraZeneca Charity Challenge is the centerpiece of a multi-year PGA TOUR partnership with AstraZeneca (NYSE:AZN). Last year, AstraZeneca donated $3.5 million through the program. Highlights from the AZCC include:

• Last week the AstraZeneca Charity Challenge winner at the Cialis Western Open was Vijay Singh. This was Singh’s ninth AstraZeneca Charity Challenge victory over the past three years

• At 19 of the 24 tournaments of 2006, the AstraZeneca Charity Challenge winner or co-winner went on to win the tournament

• More than 95 charities have benefited from the program

• Vijay Singh leads all players with nine AstraZeneca Charity Challenge wins. With some of his charitable “winnings,” Singh donated money to the American Red Cross Hurricane Relief Funds in Florida and New Orleans

• Other multiple winners have included Jim Furyk, Tom Lehman, Phil Mickelson and Rod Pampling (four), Stuart Appleby, Chad Campbell, Luke Donald, Sergio Garcia, Carl Petterson, Adam Scott and David Toms (three), and the following players who triumphed twice: Billy Andrade, Bart Bryant, Ben Curtis, Chris DiMarco, Tim Herron, Arron Oberholser, Joe Ogilvie, Kenny Perry, Ted Purdy and Tiger Woods.

Fans can log on to www.astrazeneca.pgatour.com to read about past AstraZeneca Charity Challenge winners and learn more about AstraZeneca.

About American Academy of Family Physicians Foundation

The American Academy of Family Physicians Foundation resolves to improve the health of all people by advancing the philosophy and culture of family medicine, through scientific, educational, charitable and humanitarian initiatives. To meet this mission, the Foundation develops and supports programs directed to physicians and the public, such as the Health Communication project, which aims to improve health communication and patient adherence by addressing the needs of both physicians and patients.

About American Osteopathic Foundation

For over a half century, the American Osteopathic Foundation (AOF) has served the osteopathic medical profession as the philanthropic arm of the American Osteopathic Association (AOA). Contributions to the AOF benefit thousands of osteopathic medical professionals through grants, scholarships and awards to students, physicians and osteopathic programs. The AOF is committed to supporting osteopathic medical education, research and scholarship endeavors that continue to build and advance the profession.

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world’s leading pharmaceutical companies with healthcare sales of over $21.4 billion and leading positions in sales of gastrointestinal, cardiovascular, respiratory, oncology and neuroscience products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index. Worldwide, AstraZeneca has six major research and development sites, four discovery facilities and a clinical research site. In total, AstraZeneca’s R&D organization is comprised of more 11,500 people located in seven countries including Canada, France, India, Japan, Sweden, United Kingdom and the United States.